Finance

Agios presents detailed mitapivat trial results for sickle cell

https://www.investing.com/news/company-news/agios-presents-detailed-mitapivat-trial-results-for-sickle-cell-93CH-4741036 Investing.com

I spent 8 years flood-proofing a city. Capital markets are running out of time to take El Niño seriously

Ravi S. Bhalla

Who are the winners & losers in the quantum future

https://www.investing.com/news/stock-market-news/who-are-the-winners--losers-in-the-quantum-future-4741033 Investing.com

Rhythm Pharmaceuticals reports phase 2 PWS trial results

https://www.investing.com/news/company-news/rhythm-pharmaceuticals-reports-phase-2-pws-trial-results-93CH-4741032 Investing.com

Intellia presents Phase 3 results for HAE gene therapy lonvo-z

https://www.investing.com/news/company-news/intellia-presents-phase-3-results-for-hae-gene-therapy-lonvoz-93CH-4741029 Investing.com

Gen Z fled San Francisco for Texas and Florida. Now they’re turning to Nashville and Orlando

are not likely to disappear, and people have built lives, bought homes, and put down roots in these markets,” McCready said. Corporate migration...

Why an Iran deal might not be dovish for the Fed

https://www.investing.com/news/economy-news/why-an-iran-deal-might-not-be-dovish-for--the-fed-4741030 Investing.com

Accenture cyber leads: why hiring more people won’t solve the cybersecurity talent gap

Harpreet Sidhu, Vikram Desai

Teladoc stock surges 69% after Fair Value models spotted opportunity

https://www.investing.com/news/investment-ideas/teladoc-stock-surges-69-after-fair-value-models-spotted-opportunity-93CH-4741026 Investing.com
1...533534535...8,245Page 534 of 8,245

Latest articles

spot_imgspot_img